NCICCTG OV12: An international multicentre phase III study of BAY 12-9566 (BAY) versus placebo in patients (pts) with advanced ovarian cancer (OVCA) responsive to primary surgery/paclitaxel plus platinum containing chemotherapy (CT). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hirte, Holger
  • Vergote, I
  • Jeffrey, J
  • Grimshaw, R
  • Stuart, G
  • Mendiola, C
  • Vorobiof, D
  • Carey, M
  • Coppieters, S
  • Schwartz, B
  • Tu, D
  • Sadura, A
  • Seymour, L

publication date

  • 2000